COMMISSION OF THE EUROPEAN COMMUNITIES. Draft COMMISSION DECISION



Similar documents
Having regard to the Treaty establishing the European Community, and in particular Article 95(1) thereof,

COMMISSION IMPLEMENTING REGULATION (EU) No /.. of XXX

How To Know If A Genetically Modified Potato Is Safe

EVENT REPORT. European Food Safety Authority 3. European Food Safety Authority (EFSA), Parma, Italy

Environmental Monitoring

COMMISSION REGULATION (EU) / of XXX

REGULATION (EEC) No 2309/93

Guidelines. of

COMMISSION IMPLEMENTING DECISION. of XXX. (Text with EEA relevance)

Having regard to the Treaty establishing the European Economic Community, and in particular Article 100 thereof;

COMMISSION DIRECTIVE 2003/94/EC

Definition of Minimum Performance Requirements for Analytical Methods of GMO Testing European Network of GMO Laboratories (ENGL)

Having regard to the Treaty establishing the European Community, and in particular Article 95 thereof,

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

European Commission Contract no. FIF : Users Guide to European Regulation in Biotechnology. Final Report, Part I: Complete text

Official Journal of the European Union. (Acts whose publication is obligatory)

COMMISSION REGULATION (EU) No /.. of XXX

Proposal for a COUNCIL DECISION

COMMISSION IMPLEMENTING DECISION

Annex 6: Nucleotide Sequence Information System BEETLE. Biological and Ecological Evaluation towards Long-Term Effects

002475/EU XXV. GP. Eingelangt am 18/11/13 COUNCIL OF THE EUROPEAN UNION. Brussels, 18 November 2013 (OR. en)

EUROPEAN COMMISSION GUIDANCE DOCUMENT. Key questions related to import requirements and the new rules on food hygiene and official food controls

Guidelines on operational functioning of colleges

8. Traceability 8.1 General requirements 8.2 Specific requirements for GM Food and Feed and products produced from GMOs

COMMISSION REGULATION (EU) No. of XXX

DECISIONS ADOPTED JOINTLY BY THE EUROPEAN PARLIAMENT AND THE COUNCIL

No. prev. doc.: 9392/08 SAN 77 DENLEG 48 VETER 5 Subject: EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS COUNCIL MEETING ON 9 AND 10 JUNE 2008

COUNCIL DIRECTIVE 2013/51/EURATOM

001637/EU XXV. GP. Eingelangt am 12/11/13 COUNCIL OF THE EUROPEAN UNION. Brussels, 12 November 2013 (OR. en) 16119/13

COMMISSION DECISION. of XXX

Council of the European Union Brussels, 30 June 2016 (OR. en) Mr Jeppe TRANHOLM-MIKKELSEN, Secretary-General of the Council of the European Union

ANNEX F. Organic agriculture (Art. 11) ARTICLE 1. Objectives

COMMISSION REGULATION (EU)

L 94/16 Official Journal of the European Union

Response of the German Medical Association

GUIDANCE DOCUMENT FOR COMPETENT AUTHORITIES FOR THE CONTROL OF COMPLIANCE WITH EU LEGISLATION ON:

SUPPLEMENTARY INTERNAL RULES IMPLEMENTING REGULATION (EC) N 45/2001 IN RELATION TO THE DATA PROTECTION OFFICER

COMMISSION RECOMMENDATION. of on a European resettlement scheme

Comparison of regulatory frameworks of Austria, Germany, France, and South Tyrol for GM free labelling of food products

Public Assessment Report. Decentralised Procedure

DIRECTIVE 2006/95/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. of 12 December 2006

1. Consultation of the Committee (SCFCAH)

COUNCIL OF THE EUROPEAN UNION. Brussels, 17 December 2003 (OR. en) 14994/03. Interinstitutional File: 2002/0043 (CNS) MIGR 101

DIRECTIVE 2014/32/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

COMMISSION DELEGATED REGULATION (EU) /... of

COMMISSION REGULATION (EU) No /.. of XXX

VOLUME 2A Procedures for marketing authorisation CHAPTER 1 MARKETING AUTHORISATION. November 2005

COMMISSION IMPLEMENTING REGULATION (EU)

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

Brief Summary on the Philippine B bilateral Air Services Agreement

Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

Opinion of the Panel on food contact materials, enzymes, flavourings and processing aids (CEF)

(Non-legislative acts) REGULATIONS

Methods verification. Transfer of validated methods into laboratories working routine. Dr. Manuela Schulze 1

Chapter 23 Definitions of GMO/LMO and modern biotechnology. Three different definitions but the same legal interpretation?

LEBANESE MINISTRY OF HEALTH DIRECTIVE

VOLUME 6A Procedures for marketing authorisation

Council of the European Union Brussels, 8 April 2016 (OR. en) Permanent Representatives Committee/Mixed Committee

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

TRANSATLANTIC TRADE AND INVESTMENT PARTNERSHIP

COMMISSION OF THE EUROPEAN COMMUNITIES. Draft COMMISSION DECISION

Netherlands. Agricultural Biotechnology Annual

Official Journal of the European Communities

Consolidated TEXT CONSLEG: 1991L /01/2004. produced by the CONSLEG system. of the Office for Official Publications of the European Communities

Maize 1507: toxic and inadequately tested

COMMISSION STAFF WORKING DOCUMENT. Elements of the Union greenhouse gas inventory system and the Quality Assurance and Control (QA/QC) programme

COMMISSION STAFF WORKING DOCUMENT. on the existing EU legal framework applicable to lifestyle and wellbeing apps. Accompanying the document

COUNCIL OF THE EUROPEAN UNION. Brussels, 7 October 2003 (OR. en) 12858/03 RECH 152 OC 589

Council of the European Union Brussels, 5 March 2015 (OR. en)

Overview on EFSA data requirements for the safety evaluation of food enzymes applications

STATUTORY INSTRUMENTS. S.I. No. 416 of 2014 EUROPEAN UNION (INSURANCE AND REINSURANCE GROUPS AND FINANCIAL CONGLOMERATES)(AMENDMENT) REGULATIONS 2014

Council of the European Union Brussels, 12 September 2014 (OR. en)

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS GUIDELINE FOR THE CONDUCT OF POST-MARKETING SURVEILLANCE STUDIES OF VETERINARY MEDICINAL PRODUCTS

SUPPLEMENTARY PROTECTION CERTIFICATES FOR MEDICINAL PRODUCTS

A Revised EMC Directive from Europe

Official Journal of the European Union L 182/19 DIRECTIVES

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP)

RECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING

Clinical research: where are we with the new (Paediatric) RC trial Regulation

Proposal for a COUNCIL REGULATION (EU) implementing enhanced cooperation in the area of the law applicable to divorce and legal separation

2002 No. 618 CONSUMER PROTECTION. The Medical Devices Regulations 2002

Official Journal of the European Communities

COMMISSION REGULATION. of

Audit of the control body through the monitoring of compliance with control plan. Measures for the irregularities

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE

COMMISSION DECISION. of

Having regard to the Treaty on the Functioning of the European Union, and in particular Article 114 thereof,

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL

COMMISSION RECOMMENDATION. of XXX

Authorisation and Restriction Newsletter

Proposal for a COUNCIL DECISION

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union

Transcription:

EN EN EN

COMMISSION OF THE EUROPEAN COMMUNITIES Draft Brussels, COMMISSION DECISION of authorising the placing on the market of food and feed containing, consisting of, or produced from the genetically modified potato line EH92-527-1 (BPS-25271-9) under Regulation (EC) No 1829/2003 of the European Parliament and of the Council DOES NOT NECESSARILY REPRESENT THE POSITION OF THE COMMISSION STILL UNDER INTERSERVICE CONSULTATION EN 1 EN

Draft COMMISSION DECISION of authorising the placing on the market of food and feed containing, consisting of, or produced from the genetically modified potato line EH92-527-1 (BPS-25271-9) under Regulation (EC) No 1829/2003 of the European Parliament and of the Council THE COMMISSION OF THE EUROPEAN COMMUNITIES, Having regard to the Treaty establishing the European Community, Having regard to Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modified food and feed 1, and in particular Article 7(3) thereof, Whereas: (1) On 28 February 2005, BASF Plant Science, submitted to the competent authorities of the United Kingdom an application, in accordance with Articles 5 and 17 of Regulation (EC) No 1829/2003, for the placing on the market of genetically modified potato EH92-527-1 for food and feed uses, food and feed containing, consisting, or produced from potato EH92-527-1, with the exception of cultivation. (2) Feed produced from genetically modified potato EH92-527-1 is, as for any conventional starch potato, a by-product of the starch processing and is the only intended use in the food and feed chains. (3) On 10 November 2006, the European Food Safety Authority ( Authority ) gave a favourable opinion in accordance with Articles 6 and 18 of the Regulation (EC) No 1829/2003 and concluded that it is unlikely that the placing on the market of the products containing, consisting, or produced from potato EH92-527-1 2 as described in the application (the products) will have adverse effects on human or animal health or the environment. (4) Accordingly, the Authority advised that no specific labelling requirements other than those provided for in Articles 13(1) and 25(2) of the Regulation (EC) No 1829/2003 are necessary. The Authority also considered that no specific conditions or restrictions for the placing on the market and/or specific conditions or restrictions for the use and handling, including post-market monitoring requirements, and no specific conditions for the protection of particular ecosystems/environment and/or geographical areas, as 1 OJ L 268, 18.10.2003, p 1. 2 http://www.efsa.europa.eu/en/science/gmo/gm_ff_applications/more_info/909.html EN 2 EN

provided for in point (e) of Articles 6(5) and 18(5) of the Regulation, had to be applied. (5) In its opinion, the Authority concluded that the environmental monitoring plan submitted by the applicant is in line with the intended uses of the products. This environmental monitoring will be carried out for the purpose of Commission Decision 3 concerning the placing on the market, in accordance with Directive 2001/18/EC of the European Parliament and of the Council, of a potato product (Solanum tuberosum L. line EH92-527-1) genetically modified for enhanced content of the amylopectin component of starch. (6) On 25 January 2007, following comments from the public and a report published by the World Health Organisation listing kanamycin and neomycin as 'critically important antibacterial agents for human medicine and for risk management strategies of nonhuman use', the Commission consulted the European Medicines Agency (EMEA) regarding the therapeutic relevance in human and veterinary medicine of antibiotics for which nptii gene allows resistance. Upon reception of the answer of EMEA, the Commission requested EFSA to review its earlier safety assessments of nptii gene and GM plants comprising the nptii gene in the light of this response. On 13 April 2007, EFSA confirmed its earlier safety assessments of GM plants comprising the nptii gene concluding that the presence of the nptii gene in GM plants for food and feed uses does not pose a risk to human or animal health or to the environment. (7) In the light of the above considerations, authorisation should be granted. (8) The authorisation for the cultivation and industrial use of potato EH92-527-1 is provided by Commission Decision [ concerning the placing on the market, in accordance with Directive 2001/18/EC of the European Parliament and of the Council, of a potato product (Solanum tuberosum L. line EH92-527-1) genetically modified for enhanced content of the amylopectin component of starch] that is providing for conditions for use and handling that aim to avoid any co-mingling with material derived from conventional potatoes intended for food or feed. (9) Despite these measures, it can not be excluded that the genetically modified potato and some products of the starch processing may be present in food or feed. In this case the presence of EH92-527-1 potato or products produced from EH92-527-1 potato in food and feed should be considered adventitious or technically unavoidable and should be in a proportion no higher than 0.9 per cent. (10) A unique identifier should be assigned to each GMO as provided for in Commission Regulation (EC) No 65/2004 establishing a system for the development and assignment of unique identifiers for genetically modified organisms 4. (11) All information contained in the Annex to this Decision on the authorisation of the products should be entered in the Community register of genetically modified food and feed as provided for in the Regulation. 3 4 OJ references to be completed OJ L 10, 16.1.2004, p. 5. EN 3 EN

(12) In accordance with Articles 4(2) and 16(2) of the Regulation, the conditions for authorisation of the products bind all persons placing them on the market. (13) This Decision should be notified through the Biosafety Clearing House to the Parties to the Cartagena Protocol on Biosafety to the Convention on Biological Diversity, pursuant to Articles 9(1) and 15(2), c), of Regulation (EC) No 1946/2003 of the European Parliament and of the Council of 15 July 2003 on transboundary movements of genetically modified organisms 5. (14) This Decision is in agreement with the opinion of the Standing Committee on the Food Chain and Animal Health that was delivered on ; HAS ADOPTED THIS DECISION: Article 1 Genetically modified organism and unique identifier Genetically modified potato (Solanum tuberosum L.) EH92-527-1, as specified in point (b) of the Annex, is assigned the unique identifier BPS-25271-9, as provided for in Regulation (EC) No 65/2004. Article 2 Authorisation The following products are authorised for the purposes of Article 4(2) and Article 16(2) of Regulation 1829/2003, according to the conditions specified in this Decision and its Annex: (a) feed produced from BPS-25271-9 potato; (b) foods containing, consisting of, or produced from BPS-25271-9 potato resulting from the adventitious or technically unavoidable presence of this GMO in a proportion no higher than 0.9 per cent of the food ingredients considered individually or food consisting of a single ingredient; (c) feed containing or consisting of BPS-25271-9 potato resulting from the adventitious or technically unavoidable presence of this GMO in a proportion no higher than 0.9 per cent of the feed and of each feed of which it is composed; Article 3 Labelling For the purposes of the labelling requirements laid down in Article 25(2) of Regulation (EC) No 1829/2003, the name of the organism shall be amylopectin starch potato. 5 OJ L 287, 5.11.2003, p. 1. EN 4 EN

Article 4 Monitoring for environmental effects 1. The monitoring plan for environmental effects provided for in Article 4 of Decision [ ] [concerning the placing on the market, in accordance with Directive 2001/18/EC of the European Parliament and of the Council, of a potato product (Solanum tuberosum L. line EH92-527-1) genetically modified for enhanced content of the amylopectin component of starch] shall be considered as also applicable for the purpose of this Decision. 2. The authorisation holder shall submit to the Commission annual reports on the implementation and the results of the monitoring activities. Those reports shall clearly state which parts of the reports are considered to be confidential, together with a verifiable justification for confidentiality in accordance with Article 30 of Regulation (EC) No 1829/2003. Confidential parts of such reports shall be submitted in separate documents. Article 5 Community Register The information in the Annexes to this Decision shall be entered in the Community register of genetically modified food and feed, as provided for in Article 28 of Regulation (EC) No 1829/2003. Other modifications of the Community register shall be made accordingly. Article 6 Authorisation holder The authorisation holder is BASF Plant Science, Germany. Article 7 Applicability and Validity This Decision shall be valid for a period of 10 years from the date of its notification. Article 8 Addressee This Decision is addressed to BASF Plant Science, Carl-Bosch-Str.38, D-67056 Ludwigshafen, Germany. Done at Brussels, [ ] For the Commission [ ] EN 5 EN

ANNEX I (a) Applicant and Authorisation holder: Name: Address: BASF Plant Science Carl-Bosch-Str.38, D-67056 Ludwigshafen, Germany (b) Designation and specification of the products: 1) Feed produced from BPS-25271-9 potato; 2) Foods containing, consisting of, or produced from BPS-25271-9 potato resulting from the adventitious or technically unavoidable presence of this GMO in a proportion no higher than 0.9 per cent of the food ingredients considered individually or food consisting of a single ingredient; 3) Feed containing or consisting of BPS-25271-9 potato resulting from the adventitious or technically unavoidable presence of this GMO in a proportion no higher than 0.9 per cent of the feed and of each feed of which it is composed; The genetically modified potato BPS-25271-9, as described in the application, has an altered starch composition (higher amylopectin/amylose ratio). The modification implies inhibition of the expression of granule bound starch synthase protein (GBSS) responsible for amylose biosynthesis. As a result, the starch produced has little or no amylose and consists of amylopectin which modifies the physical properties of the starch. A nptii gene, conferring kanamycin resistance, was used as a selectable marker in the genetic modification process. (c) Labelling: For the purposes of the labelling requirements laid down in Article 25(2) of Regulation (EC) No 1829/2003 and in Article 4(6) of Regulation (EC) n 1830/2003, the name of the organism shall be amylopectin starch potato. d) Method for detection: Event specific real-time quantitative PCR based method for genetically modified potato BPS-25271-9. Validated by the Community reference laboratory established under Regulation (EC) No 1829/2003, published at http://gmo-crl.jrc.it/statusofdoss.htm Reference Material: ERM -BF421 accessible via the Joint Research Centre (JRC) of the European Commission, the Institute of Reference Materials and Measurements (IRMM) at http://www.irmm.jrc.be/html/reference_materials_catalogue/index.htm (e) Unique identifier: EN 6 EN

BPS-25271-9 (f) Information required under Annex II to the Cartagena Protocol on Biosafety to the Convention on Biological Diversity: Biosafety Clearing House, Record ID: see [to be completed when notified] (g) Conditions or restrictions on the placing on the market, use or handling of the products: Not required. (h) Monitoring plan Monitoring plan for environmental effects provided for in Article 4 of Decision [ ] concerning the placing on the market, in accordance with Directive 2001/18/EC of the European Parliament and of the Council, of a potato product (Solanum tuberosum L. line EH92-527-1) genetically modified for enhanced content of the amylopectin component of starch. (i) Post market monitoring requirements for the use of the food for human consumption Not required. Note: links to relevant documents may need to be modified over the time. Those modifications will be made available to the public via the updating of the Community register of genetically modified food and feed. EN 7 EN